UBS Group
ACHC icon

UBS Group’s Acadia Healthcare ACHC Stock Holding History

UBS Group’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-148,500
Closed -$3.82M – 7679
2018
Q4 		$3.82M Buy
+148,500
New +$5.14M ﹤0.01% 2413

Other funds holding ACHC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group's ACHC Position: Q3 2026 in Review

UBS Group reduced its Acadia Healthcare (ACHC) stake by 26% in Q3 2026, selling an estimated $31.2M and leaving 3,007,600 shares worth $82.7M. The position accounts for 0.01% of the portfolio, ranked #1247.

UBS Group first reported a position in ACHC in Q4 2014 and has held it in 48 quarters since. The position peaked at $119M in Q2 2026. 211 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • UBS Group held 3,007,600 shares of Acadia Healthcare worth $82.7M as of Q3 2026.
  • UBS Group sold 1,036,900 Acadia Healthcare shares in Q3 2026, an estimated $31.2M.
  • Acadia Healthcare made up 0.01% of UBS Group's portfolio in Q3 2026, its #1247 holding.
  • UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Acadia Healthcare position peaked at $119M in Q2 2026.
  • 211 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.